This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of David Jafrancesco
Introduction
David Jafrancesco is a notable inventor based in Florence, Italy. He has made significant contributions to the field of biomedical technology, particularly in the area of in vitro diagnostics. His work focuses on enhancing the accuracy and efficiency of immunological tests through innovative systems.
Latest Patents
David Jafrancesco holds a patent for a "System for in vitro detection and/or quantification by fluorometry." This invention relates to a system designed for the in vitro detection and quantification of at least one analyte in a biological fluid sample. The system includes a radiation source, an optical splitter, and two photodetector means for detecting fluorescence and reference beams. This technology aims to improve the reliability of immunological tests by providing precise measurements of fluorescence values.
Career Highlights
David Jafrancesco is currently employed at bioMérieux, Inc., a company renowned for its commitment to advancing diagnostics and improving patient outcomes. His role involves developing innovative solutions that enhance the capabilities of diagnostic testing. With a focus on research and development, he has contributed to the advancement of technologies that are crucial for healthcare.
Collaborations
Throughout his career, David has collaborated with talented professionals, including Véronica Lucia Rossi and Giuseppe Ferorelli. These collaborations have fostered an environment of innovation and creativity, leading to the development of cutting-edge technologies in the field of diagnostics.
Conclusion
David Jafrancesco's contributions to the field of biomedical technology exemplify the impact of innovation in healthcare. His patented system for in vitro detection and quantification by fluorometry represents a significant advancement in diagnostic testing. Through his work at bioMérieux, Inc., he continues to push the boundaries of what is possible in the realm of medical diagnostics.